EAST MILLSTONE, N.J.--(BUSINESS WIRE)--Life Sciences Research, Inc. (NYSE Arca: LSR) announced today that revenues for the quarter ended December 31, 2006 of $52.5 million were 31.1% above revenues for the same period in the prior year of $40.0 million. Excluding the effect of exchange rate movements, the increase was 22.3%. Operating loss for the quarter ended December 31, 2006 was $5.0 million, or 9.6% of revenues, compared with operating income of $4.7 million, or 11.8% of revenues for the same period in the prior year. Operating loss in the quarter ended December 31, 2006 included a $10.5 million other operating expense, compared with $0 in the same period in the prior year. This 2006 charge was for costs associated with the Company’s recent NYSE Arca listing, including a $7.7 million non-cash charge for warrants issued in November 2005, and legal and advisory costs related to the animal rights extremist campaign that has targeted the company. Excluding that charge, operating income for the quarter would have been $5.5 million. The Company reported net income for the quarter ended December 31, 2006 of $1.5 million, compared with a net loss of $0.5 million for the same period in the prior year. Net income per fully diluted share for the quarter ended December 31, 2006 was $0.10 compared with a loss of $0.04 for the same period in the prior year.
